Global IV Flush Syringe Market Size

IV Flush Syringe Market Analysis

The IV flush syringe market is expected to register a CAGR of 6.0% over the forecast period, 2022-2027.

The advent of COVID-19 resulted in burdening of healthcare infrastructure worldwide as most elective healthcare treatments were postponed. Moreover, the demand for these IV flush syringes such as saline IV flush syringes and heparin IV flush syringes witnessed a decline due to a decline in hospital admission of non-covid patients. Also, the number of surgeries has been reduced due to a lack of healthcare professionals, and supply chain & logistic disruption has reduced the demand for the product in the market. Many of the patients suffering from chronic diseases were treated remotely from home to prevent the risk of disease transmission and unburden healthcare facilities. Thus, the market would undergo a negative impact due to a lack of demand for IV flush syringes.

Furthermore, increasing chronic disorders are expected to propel the demand for IV flush syringes. In the year 2020, as per the data provided by the healthcare cost & utilization project, cardiac diseases, arthritis, COPD, and diabetes are factors supporting in-patient hospital stays in the United States. For instance, In 2020, as per the Centers for Disease Control and Prevention estimates suggested a higher diagnosed prevalence of COPD in the United States with 17,455,605 diagnosed cases in 2020, which might increase in 2030, thus the increasing cases of COPD in the respective country would raise the rate of hospitalizations which would generate the need for IV flush syringes in the treatment process. Also, In the year 2019 as per a national health council study, the number is projected to grow to an estimated 157 million, with 81 million having multiple chronic conditions in the United States. Thus, the increasing number of chronic diseases is generating the need for the usage of IV flush syringes market.

Increasing awareness about the benefits of using an IV Flush Syringe also drives the growth of this market. Health care providers use IV flushes to clear out intravenous lines that deliver medicine directly into the veins of a patient. Flushes are administered before and after starting IV medication drips or fluids in patients. This ensures the lines stay clean and prevents blockages. When used correctly, IV flush syringes could make life much easier for health care providers and patients. The devices increase workflow efficiency in care settings and usually decrease the risk of infection. They also decrease the risk of needlestick injuries among health care professionals. For instance, BD PosiFlush SP Pre-Filled Saline Syringe assist in improving clinician efficiency and workflow by eliminating steps and time involved in the manual preparation of saline syringes. Thus, the advantages associated with IV Flush syringes are rising demand for the product which is boosting the market growth.

However, fluctuations in the prices of the final product are quietly hampering the demand of the market. Lack of sufficient knowledge in handling the syringes owing to few training programs is restraining the demand of the market. Replacement of other types of syringes instead of IV flush syringes is restricting the growth of the market.